| By Marketwire . | Article Rating: |
|
| October 29, 2012 03:04 AM EDT | Reads: |
251 |
SALEM, NH -- (Marketwire) -- 10/29/12 --
29 October 2012
ProPhotonix Limited
("ProPhotonix" or the "Company")
Change of name of Nominated Adviser and Broker
ProPhotonix Limited (London Stock Exchange - AIM: PPIX and PPIR, OTC:
STKR.PK), was notified of the completion of the merger between Nplus1
Brewin LLP and Singer Capital Markets Limited and that the name of the
Company's Nominated Adviser and Broker has changed to Nplus1 Singer
Advisory LLP ("N+1 Singer") with immediate effect.
Enquiries:
ProPhotonix Limited Tel: +44 (0)12 7971 7170
Mark W. Blodgett, CEO
N+1 Singer (Nominated Adviser and Broker) Tel: +44 (0) 203 201 3710
Andrew Craig / Ben Wright
Cubitt Consulting Tel: +44 (0) 207 367 5100
Chris Lane / Madeline Douglas
About ProPhotonix
ProPhotonix Limited (formerly StockerYale, Inc.), headquartered in
Salem, New Hampshire, is an independent designer and manufacturer of
diode-based laser modules and LED systems for industry leading OEMs and
medical equipment companies. In addition, the Company distributes
premium diodes for Opnext, QSI, Ondax, Sanyo and Sony. The Company
serves a wide range of markets including the machine vision, industrial
inspection, defense, sensors, and medical markets. ProPhotonix has
offices and subsidiaries in the U.S., U.K. and Ireland. For more
information about ProPhotonix and its innovative products, visit the
Company's web site at www.prophotonix.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contacts:
RNS
Customer
Services
0044-207797-4400
Email Contact
http://www.rns.com
Published October 29, 2012 Reads 251
Copyright © 2012 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By Marketwire .
Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

